Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study
出版年份 2018 全文链接
标题
Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study
作者
关键词
-
出版物
ACTA ONCOLOGICA
Volume -, Issue -, Pages 1-9
出版商
Informa UK Limited
发表日期
2018-01-31
DOI
10.1080/0284186x.2018.1433323
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cisplatin is retained in the cochlea indefinitely following chemotherapy
- (2017) Andrew M. Breglio et al. Nature Communications
- Variants inWFS1and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity
- (2016) Heather E. Wheeler et al. CLINICAL CANCER RESEARCH
- Platinum-induced ototoxicity: a review of prevailing ototoxicity criteria
- (2016) Sofia Waissbluth et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- The Sound of Silence: A Proxy for Platinum Toxicity
- (2016) Jan Oldenburg et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer
- (2016) Robert D. Frisina et al. JOURNAL OF CLINICAL ONCOLOGY
- Early ototoxic changes in patients with germ cell tumor after first cycle of cisplatin-based therapy
- (2016) László Noszek et al. LARYNGOSCOPE
- Prevalence of age-related hearing loss, including sex differences, in older adults in a large cohort study
- (2016) Nienke C. Homans et al. LARYNGOSCOPE
- Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors
- (2016) Line V. Hjelle et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Molecular targets for anticancer redox chemotherapy and cisplatin-induced ototoxicity: the role of curcumin on pSTAT3 and Nrf-2 signalling
- (2015) A R Fetoni et al. BRITISH JOURNAL OF CANCER
- Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma
- (2014) James G. Gurney et al. NEURO-ONCOLOGY
- Testicular cancer incidence to rise by 25% by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data
- (2013) Charlotte Le Cornet et al. EUROPEAN JOURNAL OF CANCER
- Cisplatin and Aminoglycoside Antibiotics: Hearing Loss and Its Prevention
- (2012) Jochen Schacht et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Long-Term and Late Effects of Germ Cell Testicular Cancer Treatment and Implications for Follow-Up
- (2012) Hege S. Haugnes et al. JOURNAL OF CLINICAL ONCOLOGY
- Occupation and the risk of bothersome tinnitus: results from a prospective cohort study (HUNT)
- (2012) Bo Engdahl et al. BMJ Open
- Impact of Long-Term Serum Platinum Concentrations on Neuro- and Ototoxicity in Cisplatin-Treated Survivors of Testicular Cancer
- (2011) Mette Sprauten et al. JOURNAL OF CLINICAL ONCOLOGY
- Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer Survivors
- (2009) M. Brydoy et al. JNCI-Journal of the National Cancer Institute
- Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
- (2009) Colin J D Ross et al. NATURE GENETICS
- Medical Treatment of Advanced Testicular Cancer
- (2008) Darren R. Feldman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search